Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Microbiome Metabolites is a biotechnology company focused on discovering and developing novel therapeutics derived from the human microbiome. The company leverages a proprietary platform to identify specific small molecule metabolites produced by gut bacteria that have potent biological activities in human health and disease. By characterizing these metabolites, the company aims to create a new class of precision medicines for inflammatory, metabolic, and oncological conditions. Their approach bridges the gap between microbiome sequencing and functional drug development by focusing on the chemical output of the microbiota.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Microbiome, Metabolites.